Investors in Technology

Piton Capital is a prominent venture capital and growth equity firm based in London, United Kingdom. Specializing in early-stage and growth-stage investments, Piton Capital focuses on backing innovative technology companies with significant potential for scalability and market impact. The firm provides strategic capital and operational support to help portfolio companies achieve accelerated growth and market leadership. With a seasoned team and a track record of successful investments, Piton Capital actively partners with visionary entrepreneurs to drive transformative outcomes in sectors such as technology, software, and digital innovation. Their approach emphasizes long-term value creation and fostering sustainable growth across their investment portfolio.

United Kingdom Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

Origin Capital, we specialize in investing in early-stage unquoted businesses and smaller quoted companies across sectors such as high-value manufacturing, life sciences, software, IT infrastructure, financial services, consumer products, and media. Our investment approach typically involves transactions ranging from £50k to £2m for unquoted businesses, with pre-money valuations between £200k and £10m. Additionally, we invest in quoted companies with market capitalizations typically ranging from £10m to £200m. Beyond funding, we offer consultancy services to both our portfolio and non-portfolio companies. Leveraging our team's diverse expertise in business consultancy, accountancy, banking, and venture capital, we aim to support the growth and operational excellence of the companies we partner with.

United Kingdom Series A/B
Above €3M

NetScientific PLC (AIM: NSCI), we are a deep tech and life sciences venture capital investment group with a diverse international portfolio of innovative companies. Based in London, United Kingdom, our focus is on identifying, investing in, and nurturing high-growth businesses both locally and globally. Our approach involves adding significant value through proactive portfolio management, guiding companies towards key value inflection points, and achieving investment returns through strategic liquidity events. We distinguish ourselves by adopting a capital-light strategy, strategically managing our balance sheet, and syndicating investments through our wholly owned VC subsidiary, EMV Capital. This lean structure allows us to effectively support a broad portfolio while maintaining flexibility and scalability. Listed on AIM, a market operated by the London Stock Exchange, we uphold our commitment to transparency and accountability in all our investment operations.

United Kingdom Pre-Seed / Seed, Series A/B
€1.5M-€3M

VGC Partners

VC Firm

VGC Partners is a growth capital investment firm focused on supporting businesses in scaling their operations and achieving significant growth milestones. They specialize in providing strategic capital to high-potential companies across various sectors, helping them expand their market presence and enhance operational capabilities. VGC Partners adopts a hands-on approach, working closely with management teams to navigate challenges and capitalize on opportunities for growth. With a commitment to long-term value creation, VGC Partners plays a pivotal role in accelerating the success of growth-stage enterprises and maximizing their potential in the competitive landscape.

United Kingdom Pre-Seed / Seed, Series A/B
€100k-€1.5M

Old College Capital serves as the venture investment arm of the University of Edinburgh, specializing in providing growth and development finance to startups. Focused on fostering innovation and entrepreneurship, they support early-stage companies across various sectors. Old College Capital leverages its deep ties to academia and industry to identify promising ventures and provide them with strategic capital and mentorship. By nurturing the commercialization of research and ideas, they contribute to the expansion of innovative solutions and technologies. Old College Capital plays a pivotal role in driving economic growth and societal impact through its investments in the vibrant startup ecosystem.

United Kingdom Pre-Seed / Seed, Series A/B
€100k-€1.5M

IQ Capital

VC Firm

IQ Capital, we're led by general partners Kerry Baldwin, Max Bautin, Simon Hirtzel, and Ed Stacey, who have collaborated for over 20 years investing in innovative Deep Tech companies. We focus on identifying companies with defensible intellectual property, breakthrough technologies, and global aspirations. Our team, rich in PhD expertise, has achieved over 20 successful exits to date, including acquisitions by industry giants like Oracle, Google, Apple, Facebook, Siemens, and various IPOs. From the Seed stage onward, we support founders in overcoming the challenges of building and scaling successful companies. Our team offers diverse perspectives rooted in deep science, technology, marketing, product-market fit, sales, talent acquisition, corporate finance, and M&A. Our investments typically range from £0.5m to £10m in disruptive Deep Tech companies across various sectors such as generative AI, advanced engineering, novel materials, space-tech, quantum hardware and algorithms, cyber and data security, and synthetic biology. Additionally, we leverage our extensive global connections to further support founders in their growth journey.

United Kingdom Pre-Seed / Seed, Series A/B, Series C & Beyond
€1.5M-€3M

Swordfish Investments, now operating as AyBe Capital, employs a comprehensive investment strategy that spans multiple asset classes. We invest directly and through funds across a diverse range of sectors including technology, media, real estate, strategic land, sports, consumer retail, and health. At Swordfish Investments (AyBe Capital), we follow our curiosities and maintain a keen interest in innovative opportunities. If a venture captivates our interest, we're eager to explore its potential. We are dedicated to partnering with ambitious entrepreneurs and founders. We understand that groundbreaking ideas require not only capital but also patience and support. Thus, we prioritize building enduring and impactful long-term relationships with our partners.

United Kingdom Series A/B
€100k-€1.5M

The UK Innovation & Science Seed Fund (UKI2S), managed by Future Planet Capital (FPC), we play a vital role in the UK's early-stage investment ecosystem. With over 20 years of experience, our mission is to support and nurture early-stage businesses and spinouts from inception to exit. We thrive on embracing risk as part of our strategy, working closely with our portfolio companies to provide extensive support. This includes helping them recruit top talent, establish robust governance frameworks, navigate fundraising challenges, and champion initiatives like Diversity, Equity & Inclusion (DE&I) and Environmental, Social, and Governance (ESG) practices. As stewards of impactful investing, we integrate rigorous impact metrics into our investment strategies to ensure our investments contribute not only to financial success but also to positive societal change and sustainable growth. Through our partnership with FPC, we are dedicated to fostering innovation and driving the success of pioneering tech ventures across the UK.

United Kingdom Pre-Seed / Seed, Series A/B
€100k-€1.5M

Octopus Group, we are both entrepreneurs and investors driven by a mission to support the people, ideas, and industries that can drive positive change in the world. As entrepreneurs, we build our own businesses to tackle significant societal challenges. Octopus Energy, our flagship energy transition business, is a prime example of this commitment. As investors, we manage £12.9 billion entrusted by our clients, directing more than 78% of these funds towards empowering people, revitalizing healthcare, and promoting a sustainable planet. At our core, we believe that how a company behaves is just as important as what it does. That’s why we chose to become an accredited B Corp (the equivalent of a Fairtrade coffee stamp but for companies) and to change our Articles of Association so that the interests of all our stakeholders – employees, customers, communities, environment, and shareholders – are considered in every decision we make. Octopus Investments, Octopus Energy, Octopus Money, Australia, Seccl Technology, Aurora, and Guardian Angel are all part of Octopus Group, working together to advance our mission.

United Kingdom Pre-Seed / Seed
€100k-€1.5M

Edenred Capital Partners is the venture capital investment arm of the Edenred Group, a global leader in payment solutions for the working world. Specializing in venture capital investments, Edenred Capital Partners focuses on supporting innovative startups that complement Edenred's expertise in payment solutions and employee benefits. They provide strategic capital and operational support to help these startups accelerate their growth and market penetration. Edenred Capital Partners leverages their industry knowledge and global network to identify and invest in promising ventures that contribute to shaping the future of payments and employee benefits solutions worldwide.

United Kingdom Pre-Seed / Seed, Series A/B, Series C & Beyond
€100k-€1.5M

Founded in 2011, we at Allegro Capital are a London-based venture capital and advisory firm focused on pre-seed and seed-stage startups. We distinguish ourselves by not being constrained like traditional funds, enabling us to take a longer, more strategic approach to our investments.

United Kingdom Series A/B
€100k-€1.5M

Syncona Partners LLP is a healthcare-focused company specializing in investing in and building global leaders in the life sciences sector. As a strategic investor, Syncona Partners LLP provides capital and operational support to life science companies, aiming to accelerate their growth and development into market leaders. They leverage their deep sector expertise and network to identify promising opportunities and nurture innovations that address significant medical challenges. Syncona Partners LLP's commitment lies in creating sustainable value and driving impactful advancements in healthcare through strategic investments and partnerships with visionary entrepreneurs and management teams.

United Kingdom Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M
Showing 409-420 of 586 items